Docking information

Jeffrey J Ayres JAyres7787 at worldnet.att.net
Thu Oct 3 15:31:33 EST 1996


There are many companies investigating small molecule drug interactions. 
 Among these are Genentech (gene.com), Roche Molecular Systems 
(roche.com), Bayer Pharmaceutical (510) 705-5000 front desk, Arris 
Pharmaceutical (arris.com) "...receptor-based discovery programs designed 
to identify small molecule drugs...", Terrapin Technologies previous work 
with GST inhibitors using molecular modeling (415) 244-9303, Onyx 
(onyx.com), Protein Design Lab (pdl.com), and Molecular Research 
Institute (415) 424 9924.  An article in J. Med. Chem. 1994, 37, 189-194
Isozyme-Specific Glutathione-S-Transferase Inhibitors:Design and 
Synthesis written by Lyttle, M.H., Hocker, M.D., Hui C.H. etal describes 
a strategy for studying "Eser Ayanoglu (spectrum)" 
<ayanoglu at cmgm.stanford.edu> wrote:
>
>Hi,
>Can anybody help me to find a good reading source for docking, small
>molecule-large molecule (drug-protein) interaction methods and also
>institutions-companies working on these subjects?  Thank you.
>
>Eser Ayanoglu
>ayanoglu at cmgm.stanford.edu
> 
>
drug protein interactions. 




More information about the Molmodel mailing list